Skip to main content
Top
Published in: Archives of Dermatological Research 3/2023

14-07-2022 | Bullous Pemphigoid | Original Paper

Association between bullous pemphigoid and atopic dermatitis: a population-based case–control study in Taiwan

Authors: Po-Chien Wu, Chun-Ying Wu, Ying-Syuan Lyu, Yun-Ting Chang, Chen-Yi Wu

Published in: Archives of Dermatological Research | Issue 3/2023

Login to get access

Abstract

Although bullous pemphigoid (BP) and atopic dermatitis (AD) share pathogenic mechanisms, their relationship remains controversial. Therefore, we conducted a population-based case–control study to investigate the association between BP and AD in Taiwan. Based on the Taiwan National Health Insurance Research Database, 9344 patients with BP and 18,688 age- and sex-matched controls were enrolled between 2000 and 2013. Furthermore, the study included 7,196 BP patients and 14,392 controls, matched for age, sex, and propensity score of comorbidities, with a case to controls ratio of 1:2. Logistic regression analysis was performed to examine the association between AD and BP. In the age- and sex-matched cohorts, AD (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.50–1.95) was independently associated with BP. In the age, sex, and comorbidities-matched cohorts, AD (OR 1.76, 95% CI 1.55–2.00) remained a significant risk factor for BP. Other significant risk factors included psoriasis, hypertension, diabetes mellitus, chronic kidney disease, chronic obstructive pulmonary disease, neuropsychiatric diseases, and autoimmune connective tissue disease. Limitations of this study include the lack of information on disease severity and phenotypes of BP and misclassification of diseases as potential sources of bias. In conclusion, AD increased the risk of developing BP by 76%, and this association was independent of many BP comorbidities. Further studies are warranted to investigate the clinical and pathophysiological relevance of factors contributing to BP and AD.
Literature
1.
go back to reference Wu CY, Wu CY, Li CP et al (2021) Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study. Diabetes Res Clin Pract 171:108546CrossRefPubMed Wu CY, Wu CY, Li CP et al (2021) Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study. Diabetes Res Clin Pract 171:108546CrossRefPubMed
2.
go back to reference Persson MSM, Harman KE, Vinogradova Y et al (2021) Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population-based cohort study. Br J Dermatol 184:68–77CrossRefPubMed Persson MSM, Harman KE, Vinogradova Y et al (2021) Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population-based cohort study. Br J Dermatol 184:68–77CrossRefPubMed
3.
go back to reference Ruggiero A, Megna M, Villani A et al (2022) Strategies to improve outcomes of bullous pemphigoid: a comprehensive review of clinical presentations, diagnosis, and patients’ assessment. Clin Cosmet Investig Dermatol 15:661–673CrossRefPubMedPubMedCentral Ruggiero A, Megna M, Villani A et al (2022) Strategies to improve outcomes of bullous pemphigoid: a comprehensive review of clinical presentations, diagnosis, and patients’ assessment. Clin Cosmet Investig Dermatol 15:661–673CrossRefPubMedPubMedCentral
4.
go back to reference Ishiura N, Fujimoto M, Watanabe R et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153–161CrossRefPubMed Ishiura N, Fujimoto M, Watanabe R et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153–161CrossRefPubMed
5.
go back to reference Moriuchi R, Nishie W, Ujiie H et al (2015) In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases. J Dermatol Sci 78:21–25CrossRefPubMed Moriuchi R, Nishie W, Ujiie H et al (2015) In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases. J Dermatol Sci 78:21–25CrossRefPubMed
6.
go back to reference Yayli S, Pelivani N, Beltraminelli H et al (2011) Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br J Dermatol 165:1133–1137CrossRefPubMed Yayli S, Pelivani N, Beltraminelli H et al (2011) Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br J Dermatol 165:1133–1137CrossRefPubMed
8.
go back to reference London VA, Kim GH, Fairley JA et al (2012) Successful treatment of bullous pemphigoid with omalizumab. Arch Dermatol 148:1241–1243CrossRefPubMed London VA, Kim GH, Fairley JA et al (2012) Successful treatment of bullous pemphigoid with omalizumab. Arch Dermatol 148:1241–1243CrossRefPubMed
9.
go back to reference Dufour C, Souillet AL, Chaneliere C et al (2012) Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 166:1140–1142CrossRefPubMed Dufour C, Souillet AL, Chaneliere C et al (2012) Successful management of severe infant bullous pemphigoid with omalizumab. Br J Dermatol 166:1140–1142CrossRefPubMed
10.
go back to reference Blome C, Radtke MA, Eissing L et al (2016) Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol 17:163–169CrossRefPubMed Blome C, Radtke MA, Eissing L et al (2016) Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol 17:163–169CrossRefPubMed
11.
go back to reference Cho YT, Hsieh WT, Chan TC et al (2020) Prevalence of baseline comorbidities in patients with atopic dermatitis: a population-based cohort study in Taiwan. JAAD International 1:50–58CrossRefPubMedPubMedCentral Cho YT, Hsieh WT, Chan TC et al (2020) Prevalence of baseline comorbidities in patients with atopic dermatitis: a population-based cohort study in Taiwan. JAAD International 1:50–58CrossRefPubMedPubMedCentral
12.
go back to reference Feld M, Garcia R, Buddenkotte J et al (2016) The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol 138(500–508):e524 Feld M, Garcia R, Buddenkotte J et al (2016) The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol 138(500–508):e524
13.
go back to reference Seidman JS, Eichenfield DZ, Orme CM (2019) Dupilumab for bullous pemphigoid with intractable pruritus. Dermatol Online J 25 Seidman JS, Eichenfield DZ, Orme CM (2019) Dupilumab for bullous pemphigoid with intractable pruritus. Dermatol Online J 25
14.
go back to reference Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43:75–84CrossRefPubMed Saeki H, Tamaki K (2006) Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43:75–84CrossRefPubMed
15.
go back to reference Kamiya K, Aoyama Y, Nishio E et al (2016) Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis. J Dermatol 43:1102–1103CrossRefPubMed Kamiya K, Aoyama Y, Nishio E et al (2016) Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis. J Dermatol 43:1102–1103CrossRefPubMed
16.
go back to reference Kagami S, Kakinuma T, Saeki H et al (2005) Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 124:1088–1090CrossRefPubMed Kagami S, Kakinuma T, Saeki H et al (2005) Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 124:1088–1090CrossRefPubMed
17.
go back to reference Kridin K, Ludwig RJ, Tzur Bitan D et al (2021) A history of asthma increases the risk of bullous pemphigoid: insights from a large population-based study. Dermatology 1–8 Kridin K, Ludwig RJ, Tzur Bitan D et al (2021) A history of asthma increases the risk of bullous pemphigoid: insights from a large population-based study. Dermatology 1–8
18.
go back to reference Kridin K, Hammers CM, Ludwig RJ, et al (2021) The association of bullous pemphigoid with atopic dermatitis and allergic rhinitis-a population-based study. Dermatitis Kridin K, Hammers CM, Ludwig RJ, et al (2021) The association of bullous pemphigoid with atopic dermatitis and allergic rhinitis-a population-based study. Dermatitis
19.
go back to reference Lin LY, Warren-Gash C, Smeeth L et al (2018) Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health 40:e2018062CrossRefPubMedPubMedCentral Lin LY, Warren-Gash C, Smeeth L et al (2018) Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health 40:e2018062CrossRefPubMedPubMedCentral
20.
go back to reference Di Zenzo G, Della Torre R, Zambruno G et al (2012) Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 30:3–16CrossRefPubMed Di Zenzo G, Della Torre R, Zambruno G et al (2012) Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 30:3–16CrossRefPubMed
21.
go back to reference Cozzani E, Gasparini G, Burlando M et al (2015) Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects. Autoimmun Rev 14:438–445CrossRefPubMed Cozzani E, Gasparini G, Burlando M et al (2015) Atypical presentations of bullous pemphigoid: clinical and immunopathological aspects. Autoimmun Rev 14:438–445CrossRefPubMed
22.
go back to reference Cozzani E, Gasparini G, Di Zenzo G et al (2018) Immunoglobulin E and bullous pemphigoid. Eur J Dermatol 28:440–448CrossRefPubMed Cozzani E, Gasparini G, Di Zenzo G et al (2018) Immunoglobulin E and bullous pemphigoid. Eur J Dermatol 28:440–448CrossRefPubMed
23.
go back to reference Kippes W, Schmidt E, Roth A et al (1999) Immunopathologic changes in 115 patients with bullous pemphigoid. Hautarzt 50:866–872CrossRefPubMed Kippes W, Schmidt E, Roth A et al (1999) Immunopathologic changes in 115 patients with bullous pemphigoid. Hautarzt 50:866–872CrossRefPubMed
24.
go back to reference Parodi A, Rebora A (1992) Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid. Br J Dermatol 126:526–527CrossRefPubMed Parodi A, Rebora A (1992) Serum IgE antibodies bind to the epidermal side of the basement membrane zone splits in bullous pemphigoid. Br J Dermatol 126:526–527CrossRefPubMed
25.
go back to reference Teraki Y, Hotta T, Shiohara T (2001) Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol 117:1097–1102CrossRefPubMed Teraki Y, Hotta T, Shiohara T (2001) Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol 117:1097–1102CrossRefPubMed
26.
go back to reference Inaoki M, Sato S, Takehara K (2004) Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. J Dermatol Sci 35:53–59CrossRefPubMed Inaoki M, Sato S, Takehara K (2004) Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. J Dermatol Sci 35:53–59CrossRefPubMed
27.
go back to reference Furukawa F, Kumagai S, Sakamoto Y et al (1994) Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid. J Dermatol Sci 7:150–154CrossRefPubMed Furukawa F, Kumagai S, Sakamoto Y et al (1994) Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid. J Dermatol Sci 7:150–154CrossRefPubMed
28.
go back to reference Kakinuma T, Wakugawa M, Nakamura K et al (2003) High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 148:203–210CrossRefPubMed Kakinuma T, Wakugawa M, Nakamura K et al (2003) High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 148:203–210CrossRefPubMed
29.
go back to reference Gounni Abdelilah S, Wellemans V, Agouli M et al (2006) Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. Clin Immunol 120:220–231CrossRefPubMed Gounni Abdelilah S, Wellemans V, Agouli M et al (2006) Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines. Clin Immunol 120:220–231CrossRefPubMed
31.
go back to reference Kaye A, Gordon SC, Deverapalli SC et al (2018) Dupilumab for the treatment of recalcitrant bullous pemphigoid. JAMA Dermatol 154:1225–1226CrossRefPubMed Kaye A, Gordon SC, Deverapalli SC et al (2018) Dupilumab for the treatment of recalcitrant bullous pemphigoid. JAMA Dermatol 154:1225–1226CrossRefPubMed
32.
go back to reference Yang YW, Chen YH, Xirasagar S et al (2011) Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42:319–323CrossRefPubMed Yang YW, Chen YH, Xirasagar S et al (2011) Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42:319–323CrossRefPubMed
33.
go back to reference Phan K, Goyal S, Murrell DF (2019) Association between bullous pemphigoid and psoriasis: systematic review and meta-analysis of case–control studies. Australas J Dermatol 60:23–28CrossRefPubMed Phan K, Goyal S, Murrell DF (2019) Association between bullous pemphigoid and psoriasis: systematic review and meta-analysis of case–control studies. Australas J Dermatol 60:23–28CrossRefPubMed
34.
go back to reference Kridin K, Bergman R (2017) Association between bullous pemphigoid and psoriasis: a case–control study. J Am Acad Dermatol 77:370–372CrossRefPubMed Kridin K, Bergman R (2017) Association between bullous pemphigoid and psoriasis: a case–control study. J Am Acad Dermatol 77:370–372CrossRefPubMed
35.
go back to reference Ho YH, Hu HY, Chang YT et al (2019) Psoriasis is associated with increased risk of bullous pemphigoid: a nationwide population-based cohort study in Taiwan. J Dermatol 46:604–609CrossRefPubMed Ho YH, Hu HY, Chang YT et al (2019) Psoriasis is associated with increased risk of bullous pemphigoid: a nationwide population-based cohort study in Taiwan. J Dermatol 46:604–609CrossRefPubMed
36.
go back to reference Cai SC, Allen JC, Lim YL et al (2015) Association of Bullous Pemphigoid and Malignant Neoplasms. JAMA Dermatol 151:665–667CrossRefPubMed Cai SC, Allen JC, Lim YL et al (2015) Association of Bullous Pemphigoid and Malignant Neoplasms. JAMA Dermatol 151:665–667CrossRefPubMed
37.
go back to reference Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123:144–151CrossRefPubMed Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123:144–151CrossRefPubMed
38.
go back to reference Paller A, Jaworski JC, Simpson EL et al (2018) Major comorbidities of atopic dermatitis: beyond allergic disorders. Am J Clin Dermatol 19:821–838CrossRefPubMed Paller A, Jaworski JC, Simpson EL et al (2018) Major comorbidities of atopic dermatitis: beyond allergic disorders. Am J Clin Dermatol 19:821–838CrossRefPubMed
39.
go back to reference Guttman-Yassky E, Krueger JG (2017) Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol 48:68–73CrossRefPubMed Guttman-Yassky E, Krueger JG (2017) Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol 48:68–73CrossRefPubMed
40.
41.
go back to reference Choy DF, Hsu DK, Seshasayee D et al (2012) Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol 130(1335–1343):e1335CrossRef Choy DF, Hsu DK, Seshasayee D et al (2012) Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol 130(1335–1343):e1335CrossRef
Metadata
Title
Association between bullous pemphigoid and atopic dermatitis: a population-based case–control study in Taiwan
Authors
Po-Chien Wu
Chun-Ying Wu
Ying-Syuan Lyu
Yun-Ting Chang
Chen-Yi Wu
Publication date
14-07-2022
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 3/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-022-02372-w

Other articles of this Issue 3/2023

Archives of Dermatological Research 3/2023 Go to the issue